Collaborative project with @nbagaoglu@DrHQRana and @unl_xo and many others is now out in Cancers. This work characterizes CHEK2 variants detected among individuals who underwent genetic testing in Turkey. See: https://t.co/7FL83hknr8
Do cancers always have a genetic component?
Huma Rana, MD, MPH, clinical director of Cancer Genetics and Prevention at Dana-Farber, explains how 15% of cancers are linked to inherited mutations. https://t.co/KavvN95Ho6
Excited to announce I'll speak at the IBG Izmir Biomedicine and Genome Center seminar! My talk will cover our team's unique insights into #HereditaryCancer🔬
📅 Date: 20.09.2024 | 11:00
📍 Location: IBG Izmir Biomedicine and Genome Center, Aziz Sancar Auditorium
@RareDiseasesIBG
What happens when #hereditarycancer testing identifies two pathogenic variants? We compared cancer risk in >600 individuals with double PVs to those with a single PV in this publication with @DanaFarber. https://t.co/cwrWgLkuWz #genechat#genechatpubs @nbagaglu @DrBBychkovsky
Insights of #cancer burden from a large retrospective study: patients with double pathogenic variants in cancer predisposition genes showed greater burden than those with single gene variants https://t.co/EkRtw2VYI6 @DrHQRana#GIMO#MultiplePathogenicVariants#BreastCancer
Adalet bir gün herkese lazım olacak!
“Bir oyuncuyu öldürdükleri gün veya en sevdiği şeyi yapmasını engelleyerek sakat bıraktıkları gün, ya da bir hakeme saldırdıkları gün beni hatırlayacaksınız.”
𝟬𝟰.𝟬𝟵.𝟮𝟬𝟮𝟮
Josef de Souza
Şiddete maruz kalan Halil Umut Meler’e geçmiş olsun dileklerimizi iletiyor, daha önce alınan kararların aksine; spor ile hiç bağdaşmayan bu eylemi yapanların en ağır şekilde cezalandırılmasını diliyor ve saldırıyı gerçekleştirenleri kınıyoruz.
Ambry talked with Dr. Huma Q. Rana about her Journal of Clinical Oncology article. She says, “It is imperative to identify service delivery models to help us meet the increasing demand for timely access to genetic testing.” Check out the full article: https://t.co/jYhN92TX0a
Congratulations @DrBBychkovsky and colleagues on your @JAMAOnc publication examining "Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2" #BreastCancer#bcsm